These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8117524)

  • 1. [The pharmacology and clinical aspects of the prostanoids].
    Ambrosioni E; Degli Esposti D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():59S-65S. PubMed ID: 8117524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
    Heidrich H
    Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin releasing polymers - stability and efficacy.
    McRea JC; Ebert CD; Kim SW
    Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possibilities for clinical use of prostacyclin in vascular disease.
    Poredos P
    Pflugers Arch; 2000; 440(5 Suppl):R137-8. PubMed ID: 11005643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease.
    Schrör K; Hohlfeld T
    Vasa; 2004 Aug; 33(3):119-24. PubMed ID: 15461062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine.
    Ylä-Herttuala S; Rissanen TT; Vajanto I; Hartikainen J
    J Am Coll Cardiol; 2007 Mar; 49(10):1015-26. PubMed ID: 17349880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular effects of prostacyclin].
    Chaignon M; Guelpa G; Lucsko M; Guédon J
    Nouv Presse Med; 1982 Dec; 11(50):3717-21. PubMed ID: 6763197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
    de Donato G; Gussoni G; de Donato G
    Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Special aspects of therapy of non-atherosclerotic vascular diseases].
    Schellong SM
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):645-9. PubMed ID: 10666828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.
    Grant SM; Goa KL
    Drugs; 1992 Jun; 43(6):889-924. PubMed ID: 1379160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
    [No Abstract]   [Full Text] [Related]  

  • 13. Review: recent advances in lipid microsphere technology for targeting prostaglandin delivery.
    Mizushima Y; Hoshi K
    J Drug Target; 1993; 1(2):93-100. PubMed ID: 8069557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease.
    Sinzinger H; Virgolini I; O'Grady J
    Prog Clin Biol Res; 1989; 301():85-96. PubMed ID: 2477859
    [No Abstract]   [Full Text] [Related]  

  • 15. An antagonist of prostaglandin synthesis in cardiovascular diseases.
    Viinikka L
    Ann Clin Res; 1984; 16(5-6):262-8. PubMed ID: 6398664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of peripheral vascular disease: are there new perspectives?
    Smit AJ
    Vasa Suppl; 1992; 34():20-4. PubMed ID: 1529413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A; Rieger H
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects of prostanoid therapy. Preliminary results.
    Castagno PL; Di Molfetta L; Merlo M; Barile G; Violato F; Buzzacchino A; Ponzio F
    Minerva Cardioangiol; 2000; 48(1-2):9-18. PubMed ID: 10829583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefits of iloprost, a stable prostacyclin (PGI2) analog, in severe peripheral arterial disease (PAD).
    Oberender H; Krais T; Schäfer M; Belcher G
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():311-6. PubMed ID: 2473610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.